Janeen Doyle, an officer at Janux Therapeutics, has executed a stock sale amounting to $56,943. This transaction reflects her decision to divest a portion of her holdings in the company. Details regarding the specific number of shares sold or the reasons for the sale have not been disclosed. The sale is part of the regular trading activities associated with corporate officers.
Related Articles
Don't miss out on breaking stories and in-depth articles.